Phase 1 Stdy to Eval the Saf, Tolerability, and Pharmacokin of Escalating Dose of Albuferon Recombinant Human Albumin- Grant uri icon

date/time interval

  • March 20, 2001 - February 25, 2006

total award amount

  • 19474.50